On the role of endogenously produced TNF-alpha and IL-6 as regulators of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro.

[1]  L. Larsson,et al.  Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells. , 1993, Leukemia.

[2]  M Schena,et al.  Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. , 1992, Blood.

[3]  M. Pettersson,et al.  Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. , 1992, Leukemia.

[4]  G. Gaidano,et al.  Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. , 1992, Leukemia.

[5]  D. Joshua,et al.  Interleukin 4 and 6 Receptor Expression on B Cell Lines and the Lymphocytes of Patients with B Cell Malignancies , 1992 .

[6]  B. Dörken,et al.  Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. , 1991, Clinical immunology and immunopathology.

[7]  P. Froom,et al.  Increased spontaneous secretion of IL‐6 from B cells of patients with B chronic lymphatic leukaemia (B‐CLL) and autoimmunity , 1991, Clinical and experimental immunology.

[8]  B. Andersson,et al.  Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. , 1991, Clinical and experimental immunology.

[9]  A. Fauci,et al.  IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. , 1991, Journal of immunology.

[10]  M Schena,et al.  Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells. , 1991, Blood.

[11]  J. Rossi,et al.  In vitro Activation of B-CLL Cells. , 1991, Leukemia & lymphoma.

[12]  A. Berrebi,et al.  Tumor Necrosis Factor Production in B Cell Chronic Lymphocytic Leukemia. , 1991, Leukemia & lymphoma.

[13]  W. Digel,et al.  Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo , 1990 .

[14]  R. Foà,et al.  Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. , 1990, Blood.

[15]  A. Freedman.  Immunobiology of chronic lymphocytic leukemia. , 1990, Hematology/oncology clinics of North America.

[16]  P. Lipsky,et al.  IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). , 1990, Journal of immunology.

[17]  S. Fournier,et al.  Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. , 1990, Leukemia research.

[18]  T. Hirano,et al.  Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. , 1989, Journal of immunology.

[19]  T. Barbui,et al.  Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. , 1989, Blood.

[20]  H. Heimpel,et al.  Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. , 1989, Blood.

[21]  F. Herrmann,et al.  High-Level Secretion of Tumor Necrosis Factor-alpha Contributes to Hematopoietic Failure in Hairy Cell Leukemia , 1989 .

[22]  C. Y. Wang,et al.  Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells , 1988, The Journal of experimental medicine.

[23]  G. Tosato,et al.  Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. , 1988, Journal of immunology.

[24]  H. Drexler,et al.  Analysis of signal transduction in B chronic lymphocytic leukemia cells. , 1988, Blood.

[25]  M. Turner,et al.  TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.

[26]  N. Ling,et al.  Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents. , 1988, Leukemia.

[27]  T. Tötterman,et al.  Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA. , 1988, Blood.

[28]  A. Fauci,et al.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells , 1987, The Journal of experimental medicine.

[29]  T. Hirano,et al.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Brouet,et al.  Interleukin 2-induced proliferation of leukemic human B cells , 1985, The Journal of experimental medicine.

[31]  T. Tötterman,et al.  Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells , 1980, Nature.

[32]  R. Winchester,et al.  Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. , 1974, Proceedings of the National Academy of Sciences of the United States of America.